Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
34,778
datasets available to search
ShareScore release 0.9.0
Dataset results
34,778 results for “diseases”
A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indet
ClinicalTrials.gov study NCT06097663. IPD Sharing: YES. Countries: 3. Publications: 1.
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
ClinicalTrials.gov study NCT04429503. IPD Sharing: YES. Countries: 8. Publications: 3.
Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA Disease
ClinicalTrials.gov study NCT02060526. IPD Sharing: YES. Countries: 8. Publications: 1.
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
ClinicalTrials.gov study NCT03104413. IPD Sharing: YES. Countries: 43. Publications: 5.
Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients
ClinicalTrials.gov study NCT04524507. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease
ClinicalTrials.gov study NCT02140554. IPD Sharing: YES. Countries: 1. Publications: 5.
A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Rec
ClinicalTrials.gov study NCT04929249. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients
ClinicalTrials.gov study NCT02337725. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03105128. IPD Sharing: YES. Countries: 44. Publications: 7.
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
ClinicalTrials.gov study NCT01915303. IPD Sharing: YES. Countries: 16. Publications: 1.
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
ClinicalTrials.gov study NCT01768637. IPD Sharing: YES. Countries: 1. Publications: 2.
The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04389671. IPD Sharing: NO. Countries: 2. Publications: 2.
A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants
ClinicalTrials.gov study NCT03710486. IPD Sharing: YES. Countries: 2. Publications: 1.
Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)
ClinicalTrials.gov study NCT02611817. IPD Sharing: YES. Countries: 30. Publications: 1.
Families-At-risk for Interstitial Lung Disease Study
ClinicalTrials.gov study NCT03641742. IPD Sharing: YES. Countries: 1. Publications: 5.
Safety and Efficacy of LCI699 in Cushing's Disease Patients
ClinicalTrials.gov study NCT01331239. IPD Sharing: YES. Countries: 4. Publications: 2.
A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease Prevention
ClinicalTrials.gov study NCT04545489. IPD Sharing: YES. Countries: 1. Publications: 2.
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
ClinicalTrials.gov study NCT02713256. IPD Sharing: YES. Countries: 2. Publications: 2.
Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
ClinicalTrials.gov study NCT01327846. IPD Sharing: YES. Countries: 40. Publications: 18.
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov study NCT03546907. IPD Sharing: YES. Countries: 10. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.